These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2556260)

  • 1. Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions.
    Adachi Y; Käs E; Laemmli UK
    EMBO J; 1989 Dec; 8(13):3997-4006. PubMed ID: 2556260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics.
    Käs E; Laemmli UK
    EMBO J; 1992 Feb; 11(2):705-16. PubMed ID: 1311255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for chromatin opening: stimulation of topoisomerase II and restriction enzyme cleavage of chromatin by distamycin.
    Käs E; Poljak L; Adachi Y; Laemmli UK
    EMBO J; 1993 Jan; 12(1):115-26. PubMed ID: 8381347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly preferential nucleation of histone H1 assembly on scaffold-associated regions.
    Izaurralde E; Käs E; Laemmli UK
    J Mol Biol; 1989 Dec; 210(3):573-85. PubMed ID: 2614834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
    Fesen M; Pommier Y
    J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of DNA binding to nuclear scaffolds and histone H1 by distamycin. The role of oligo(dA).oligo(dT) tracts.
    Käs E; Izaurralde E; Laemmli UK
    J Mol Biol; 1989 Dec; 210(3):587-99. PubMed ID: 2614835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preferential binding of histone H1 to DNA scaffold-associated regions is determined by its C-terminal domain.
    Roque A; Orrego M; Ponte I; Suau P
    Nucleic Acids Res; 2004; 32(20):6111-9. PubMed ID: 15562002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of topoisomerase II-mediated cleavage sites and relation to structural and functional landmarks in 830 kb of Drosophila DNA.
    Miassod R; Razin SV; Hancock R
    Nucleic Acids Res; 1997 Jun; 25(11):2041-6. PubMed ID: 9153300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.
    Bell A; Kittler L; Löber G; Zimmer C
    Invest New Drugs; 1996; 13(4):271-84. PubMed ID: 8824345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Position-specific effect of ribonucleotides on the cleavage activity of human topoisomerase II.
    Wang Y; Thyssen A; Westergaard O; Andersen AH
    Nucleic Acids Res; 2000 Dec; 28(24):4815-21. PubMed ID: 11121471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-strand DNA cleavages by eukaryotic topoisomerase II.
    Muller MT; Spitzner JR; DiDonato JA; Mehta VB; Tsutsui K; Tsutsui K
    Biochemistry; 1988 Nov; 27(22):8369-79. PubMed ID: 2853964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
    Kingma PS; Corbett AH; Burcham PC; Marnett LJ; Osheroff N
    J Biol Chem; 1995 Sep; 270(37):21441-4. PubMed ID: 7665552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic topoisomerase II cleavage is independent of duplex DNA conformation.
    Choi IY; Chung IK; Muller MT
    Biochim Biophys Acta; 1995 Nov; 1264(2):209-14. PubMed ID: 7495865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.
    Mortensen UH; Stevnsner T; Krogh S; Olesen K; Westergaard O; Bonven BJ
    Nucleic Acids Res; 1990 Apr; 18(8):1983-9. PubMed ID: 2159632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal DNA requirement for topoisomerase II-mediated cleavage in vitro.
    Lund K; Andersen AH; Christiansen K; Svejstrup JQ; Westergaard O
    J Biol Chem; 1990 Aug; 265(23):13856-63. PubMed ID: 2166042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of 5' and 3' DNA triplex interference boundaries reveals the core DNA binding sequence for topoisomerase II.
    Spitzner JR; Chung IK; Muller MT
    J Biol Chem; 1995 Mar; 270(11):5932-43. PubMed ID: 7890724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the simultaneous binding of eukaryotic DNA topoisomerase II to a pair of double-stranded DNA helices.
    Roca J; Berger JM; Wang JC
    J Biol Chem; 1993 Jul; 268(19):14250-5. PubMed ID: 8390987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
    Riou JF; Grondard L; Naudin A; Bailly C
    Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A consensus sequence for cleavage by vertebrate DNA topoisomerase II.
    Spitzner JR; Muller MT
    Nucleic Acids Res; 1988 Jun; 16(12):5533-56. PubMed ID: 2838820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G; Tolstonog GV; Sabasch M; Traub P
    DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.